Cochlear implants are electronic medical devices, which are used to replace the function of the inner ear, when damaged. Unlike other hearing aids, cochlear implants are used to bypass the damaged hair cells of the inner ear (cochlea) to facilitate transfer of sound signals to the brain. These implants are useful for patients suffering from average-to-extreme hearing loss in both ears.
The global cochlear implants market is driven by increase in geriatric population contributing to a large patient pool, rise in product customization, and introduction of rechargeable cochlear implants. However, high cost of the device, issues in cochlear batteries, and constrained healthcare expenditure restrain the market growth. Conversely, recent advancements for developing innovative next generation sound processors and emerging potential markets provide lucrative opportunities for the market growth.
The global cochlear implants market is segmented on the basis of fitting type, end user, and geography. Based on fitting type, it is classified into unilateral and bilateral implantation. On basis of end user, it is bifurcated into pediatrics and adults. Geographically, it is analyzed in across four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in the market are Cochlear Ltd., MED-EL GmbH, Sonova Holding AG, William Demant Holding A/S, Starkey, Nurotron Biotechnology Co. Ltd., Widex USA, Inc., Cochlear Ltd., Advanced Bionics AG, and Oticon Medical.
- The report presents the market analysis of the global cochlear implants market along with the regional trend and future estimations.
- It provides extensive information about the market segments from 2016 to 2023 to understand the market dynamics.
- The key factors that drive, hamper, or provide opportunities to the market are provided in the report
- Competitive landscape of the industry along with the profile analysis of market players is provided in the report.
Cochlear Implants Market Key Segments
By Fitting Type
- Unilateral Implantation
- Bilateral Implantation
By End User
- North America
- Rest of Europe
- Rest of Asia-Pacific
- South Africa
- Saudi Arabia
- Rest of LAMEA